Donate Today

State Cannabis Legalization and Psychosis-Related Health Care Utilization

Published
01/25/2023
Developed by
ICUDDR
Resource Type
Related Topics
Materials
External Link
Read more

Objective  To evaluate the association of state medical and recreational cannabis laws and commercialization with rates of psychosis-related health care utilization.

Main Outcomes and Measures  Outcomes were rates of psychosis-related diagnoses and prescribed antipsychotics.

Conclusions and Relevance  In this retrospective cohort study of commercial and Medicare Advantage claims data, state medical and recreational cannabis policies were not associated with a statistically significant increase in rates of psychosis-related health outcomes. As states continue to introduce new cannabis policies, continued evaluation of psychosis as a potential consequence of state cannabis legalization may be informative.

chevron-down